MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering

Rémi Montagne(Institut Pasteur de Lille), David Tulasne(Centre National de la Recherche Scientifique)

Oncotarget

January 4, 2017

10.18632/oncotarget.14499

Cited by 10

Related Papers

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

|JNCI Journal of the National Cancer Institute|2016|121

Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside

|Cancer Research|2014|68

Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity

|Cell Death and Disease|2013|36

Transforming properties of <scp>MET</scp> receptor exon 14 skipping can be recapitulated by loss of the <scp>CBL</scp> ubiquitin ligase binding site

|FEBS Letters|2023|18